{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:10:09Z","timestamp":1788772209068,"version":"build-2803163510"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jviromet.2026.115447","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:18:01Z","timestamp":1786547881000},"page":"115447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emerging techniques of CRISPR\/Cas system in antiviral therapy and diagnostics: Applications, limitations, and translational perspectives"],"prefix":"10.1016","volume":"346","author":[{"given":"Mahmood Ul","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Waleed","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Noor-ul-Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2322-7015","authenticated-orcid":false,"given":"Marriam","family":"Khurshid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsre\/fuw044","article-title":"An expanded view of viruses","volume":"41","author":"Greber","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.jviromet.2026.115447_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2018.06.002","article-title":"Engineering virus resistance via CRISPR\u2013Cas systems","volume":"32","author":"Mahas","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jviromet.2026.115447_bib3","article-title":"Original hosts, clinical features, transmission routes, and vaccine development for coronavirus disease (COVID-19)","volume":"8","author":"Wu","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.jviromet.2026.115447_bib4","unstructured":"WHO, Global hepatitis report 2024: action for access in low- and middle-income countries. 2024."},{"key":"10.1016\/j.jviromet.2026.115447_bib5","unstructured":"CDC. Global Viral Hepatitis. 2025; Available from: https:\/\/www.cdc.gov\/hepatitis\/global\/index.html."},{"key":"10.1016\/j.jviromet.2026.115447_bib6","unstructured":"UNAIDS, Global HIV & AIDS statistics \u2014 Fact sheet. 2025."},{"key":"10.1016\/j.jviromet.2026.115447_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114925","article-title":"Investigating purification and activity analysis of urease enzyme extracted from jack bean source: a green chemistry approach","volume":"659","author":"Pawar","year":"2022","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jviromet.2026.115447_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-981-16-6305-5_10","article-title":"Challenges and future prospects of CRISPR technology","author":"Khan","year":"2022","journal-title":"CRISPR\/Cas. Tool. Kit Genome Ed."},{"key":"10.1016\/j.jviromet.2026.115447_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199314","article-title":"Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications","volume":"341","author":"Zahedipour","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.jviromet.2026.115447_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00018-013-1438-6","article-title":"Molecular mechanisms of CRISPR-mediated microbial immunity","volume":"71","author":"Gasiunas","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"19","key":"10.1016\/j.jviromet.2026.115447_bib11","first-page":"10173","article-title":"CRISPR\u2013Cas adaptation in Escherichia coli requires RecBCD helicase but not nuclease activity, is independent of homologous recombination, and is antagonized by 5\u2032 ssDNA exonucleases","volume":"46","author":"Radov\u010di\u0107","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5483\/BMBRep.2023-0050","article-title":"Harnessing CRISPR-Cas adaptation for RNA recording and beyond","volume":"57","author":"Oh","year":"2024","journal-title":"BMB Rep."},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib13","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20221198","article-title":"CRISPR-Cas adaptation in Escherichia coli","volume":"43","author":"Miti\u0107","year":"2023","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib14","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/nar\/gkab105","article-title":"Mechanisms of spacer acquisition by sequential assembly of the adaptation module in Synechocystis","volume":"49","author":"Wu","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"10.1016\/j.jviromet.2026.115447_bib15","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.3390\/ijms21186461","article-title":"Methods favoring homology-directed repair choice in response to CRISPR\/Cas9 induced-double strand breaks","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR\u2013Cas9 structures and mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu. Rev. Biophys."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s11658-024-00581-x","article-title":"Emerging technology has a brilliant future: the CRISPR-Cas system for senescence, inflammation, and cartilage repair in osteoarthritis","volume":"29","author":"Jia","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"10","key":"10.1016\/j.jviromet.2026.115447_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/cells13100800","article-title":"CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments","volume":"13","author":"Laurent","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jviromet.2026.115447_bib19","series-title":"Genome Engineering via CRISPR-Cas9 System","first-page":"281","article-title":"Emergent challenges for CRISPR: biosafety, biosecurity, patenting, and regulatory issues","author":"Braddick","year":"2020"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/magnetochemistry9030071","article-title":"Delivery of dCas9 activator system using magnetic nanoparticles technology as a vector delivery method for human skin fibroblast","volume":"9","author":"Mohammadi Ghanbarlou","year":"2023","journal-title":"Magnetochemistry"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymthe.2021.12.006","article-title":"Anti-Cas9 immunity: A formidable challenge for muscle genome editing","volume":"30","author":"Lagor","year":"2022","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1089\/crispr.2022.0051","article-title":"Advances in CRISPR delivery methods: perspectives and challenges","volume":"5","author":"Demirci","year":"2022","journal-title":"CRISPR J."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib23","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/s41467-021-26830-7","article-title":"Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models","volume":"12","author":"Hakim","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jviromet.2026.115447_bib24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/1389450123666220117105531","article-title":"A review on CRISPR-mediated epigenome editing: A future directive for therapeutic management of cancer","volume":"23","author":"Chakravarti","year":"2022","journal-title":"Curr. Drug. Targets"},{"key":"10.1016\/j.jviromet.2026.115447_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fcimb.2017.00091","article-title":"Removal of integrated hepatitis B virus DNA using CRISPR-Cas9","volume":"7","author":"Li","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.jviromet.2026.115447_bib26","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00018-019-03021-8","article-title":"Orthologous CRISPR\/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus","volume":"76","author":"Kostyushev","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib27","article-title":"Challenges of CRISPR\/Cas9 applications for long non-coding RNA genes","volume":"45","author":"Goyal","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal structure of Cas9 in complex with guide RNA and target DNA","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell"},{"issue":"6096","key":"10.1016\/j.jviromet.2026.115447_bib29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"science"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib30","doi-asserted-by":"crossref","first-page":"15577","DOI":"10.1038\/srep15577","article-title":"Genome editing of CXCR4 by CRISPR\/cas9 confers cells resistant to HIV-1 infection","volume":"5","author":"Hou","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jviromet.2026.115447_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300605120","article-title":"Altered DNA repair pathway engagement by engineered CRISPR-Cas9 nucleases","volume":"120","author":"Chauhan","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jviromet.2026.115447_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102344","article-title":"CRISPR-Cas9-mediated homology-directed repair for precise gene editing","volume":"35","author":"Liao","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nbt.3190","article-title":"Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining","volume":"33","author":"Maruyama","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2026.115447_bib34","unstructured":"Liu, Y., et al., (n.d.). Multi-targets cleavage of BmNPV genome through genome-wide repeat sequence using CRISPR\/Cas9 antiviral system. Insect Science."},{"issue":"7","key":"10.1016\/j.jviromet.2026.115447_bib35","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/molecules24071349","article-title":"CRISPR\/Cas9-based antiviral strategy: current status and the potential challenge","volume":"24","author":"Lee","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/v16030409","article-title":"Modulation of Equid Herpesvirus-1 Replication Dynamics In Vitro Using CRISPR\/Cas9-Assisted Genome Editing","volume":"16","author":"Hassanien","year":"2024","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jviromet.2026.115447_bib37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/microorganisms12020314","article-title":"CRISPR\/Cas9-Mediated Knockout of the HuR Gene in U251 Cell Inhibits Japanese Encephalitis Virus Replication","volume":"12","author":"Luo","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.jviromet.2026.115447_bib38","article-title":"CRISPR\/Cas-based nucleic acid detection strategies: Trends and challenges","author":"Zhou","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jviromet.2026.115447_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116046","article-title":"CRISPR\/Cas9-mediated SERS\/colorimetric dual-mode lateral flow platform combined with smartphone for rapid and sensitive detection of Staphylococcus aureus","volume":"249","author":"Wang","year":"2024","journal-title":"Biosens. Bioelectron."},{"issue":"4","key":"10.1016\/j.jviromet.2026.115447_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202000315","article-title":"CRISPR\/Cas technology as a promising weapon to combat viral infections","volume":"43","author":"Escalona-Noguero","year":"2021","journal-title":"BioEssays"},{"key":"10.1016\/j.jviromet.2026.115447_bib41","series-title":"Seminars in cancer biology","article-title":"The human papillomavirus family and its role in carcinogenesis","author":"Tommasino","year":"2014"},{"issue":"2","key":"10.1016\/j.jviromet.2026.115447_bib42","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171268","article-title":"Prevalence and type distribution of human papillomavirus (HPV) in Malaysian women with and without cervical cancer: an updated estimate","volume":"38","author":"Tan","year":"2018","journal-title":"Biosci. Rep."},{"issue":"6","key":"10.1016\/j.jviromet.2026.115447_bib43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/17425247.2020.1747429","article-title":"Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy","volume":"17","author":"Aghamiri","year":"2020","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/j.jviromet.2026.115447_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.virol.2021.07.005","article-title":"CRISPR\/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells","volume":"562","author":"Inturi","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2026.115447_bib45","unstructured":"Bruni, L., et al., Human papillomavirus and related diseases in the world, in Summary report, I.I.I.C.o.H.a.C.H.I. Centre), Editor. 2023."},{"issue":"7","key":"10.1016\/j.jviromet.2026.115447_bib46","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/v15071440","article-title":"Recent developments in human papillomavirus (HPV) vaccinology","volume":"15","author":"Williamson","year":"2023","journal-title":"Viruses"},{"issue":"9574","key":"10.1016\/j.jviromet.2026.115447_bib47","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2026.115447_bib48","doi-asserted-by":"crossref","first-page":"K53","DOI":"10.1016\/j.vaccine.2008.06.002","article-title":"An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results","volume":"26","author":"Schiller","year":"2008","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.jviromet.2026.115447_bib49","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1128\/JVI.01879-14","article-title":"Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR\/Cas RNA-guided endonuclease","volume":"88","author":"Kennedy","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2026.115447_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112743","article-title":"Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections","volume":"148","author":"Najafi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jviromet.2026.115447_bib51","unstructured":"Shimizu, Y. Hepatitis - World Health Organization. 2022; Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/chronic-viral-hepatitis#:\u223c:text=An%20estimated%201.3%20million%20people,with%20viral%20hepatitis%20each%20day."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib52","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/s41598-019-38526-6","article-title":"Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR\/Cas9","volume":"9","author":"Kostyushev","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jviromet.2026.115447_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.68","article-title":"Targeting hepatitis B virus with CRISPR\/Cas9","volume":"3","author":"Seeger","year":"2014","journal-title":"Mol. Ther. -Nucleic Acids"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib54","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.1038\/srep13734","article-title":"CRISPR\/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X","volume":"5","author":"Karimova","year":"2015","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib55","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/17474124.2023.2196405","article-title":"Chronic hepatitis B: A scoping review on the guidelines for stopping nucleos (t) ide analogue therapy","volume":"17","author":"Hui","year":"2023","journal-title":"Expert. Rev. Gastroenterol. & Hepatol."},{"issue":"2","key":"10.1016\/j.jviromet.2026.115447_bib56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.gastro.2008.05.031","article-title":"Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon \u03b1-2b","volume":"135","author":"Buster","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2026.115447_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2024.1467449","article-title":"The potential of HBV cure: an overview of CRISPR-mediated HBV gene disruption","volume":"6","author":"Yao","year":"2024","journal-title":"Front. Genome Ed."},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.DMIH2-0011-2015","article-title":"Epstein-barr virus","volume":"4","author":"Nowalk","year":"2016","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0005728","article-title":"Prevalence of CMV, EBV, HPV, and HSV among South Asian healthy population: A systematic review and meta-analysis","volume":"6","author":"Ahmed","year":"2026","journal-title":"PLOS Glob. Public. Health"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib60","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1099\/jgv.0.000012","article-title":"CRISPR\/Cas9-mediated genome editing of Epstein\u2013Barr virus in human cells","volume":"96","author":"Yuen","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2026.115447_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13027-019-0246-5","article-title":"CRISPR\/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth","volume":"14","author":"Huo","year":"2019","journal-title":"Infect. Agents Cancer"},{"issue":"4","key":"10.1016\/j.jviromet.2026.115447_bib62","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1073\/pnas.72.4.1477","article-title":"Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells","volume":"72","author":"Adams","year":"1975","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/14760584.2019.1605906","article-title":"Prophylactic and therapeutic strategies for Epstein\u2013Barr virus-associated diseases: emerging strategies for clinical development","volume":"18","author":"Dasari","year":"2019","journal-title":"Expert. Rev. Vaccin."},{"issue":"23","key":"10.1016\/j.jviromet.2026.115447_bib64","first-page":"6952","article-title":"Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma","volume":"62","author":"Lin","year":"2002","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jviromet.2026.115447_bib65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2747","article-title":"The structural biology of HIV-1: mechanistic and therapeutic insights","volume":"10","author":"Engelman","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.jviromet.2026.115447_bib66","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1089\/hum.2018.018","article-title":"CRISPR\/Cas9 inhibits multiple steps of HIV-1 infection","volume":"29","author":"Yin","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jviromet.2026.115447_bib67","unstructured":"Cohrt, K.O.H. Clinical Trial Update: Positive Clinical Data for First Ever CRISPR Therapy for HIV. 2023; Available from: https:\/\/crisprmedicinenews.com\/news\/clinical-trial-update-positive-clinical-data-for-first-ever-crispr-therapy-for-hiv\/."},{"key":"10.1016\/j.jviromet.2026.115447_bib68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1590\/1678-4685-gmb-2017-0065","article-title":"Comparison of the editing patterns and editing efficiencies of TALEN and CRISPR-Cas9 when targeting the human CCR5 gene","volume":"41","author":"Nerys-Junior","year":"2018","journal-title":"Genet. Mol. Biol."},{"issue":"6151","key":"10.1016\/j.jviromet.2026.115447_bib69","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1241144","article-title":"Antibodies in HIV-1 vaccine development and therapy","volume":"341","author":"Klein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2026.115447_bib70","article-title":"Next-generation bNAbs for HIV-1 cure strategies","author":"Schriek","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jviromet.2026.115447_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25829","article-title":"Broadly neutralizing monoclonal antibodies for HIV prevention","volume":"24","author":"Miner","year":"2021","journal-title":"J. Int. AIDS Soc."},{"issue":"2","key":"10.1016\/j.jviromet.2026.115447_bib72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tibs.2014.12.006","article-title":"Insights into the trimeric HIV-1 envelope glycoprotein structure","volume":"40","author":"Ward","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"6929","key":"10.1016\/j.jviromet.2026.115447_bib73","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2026.115447_bib74","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3389\/fmicb.2017.01425","article-title":"The exceptional oncogenicity of HTLV-1","volume":"8","author":"Tagaya","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jviromet.2026.115447_bib75","doi-asserted-by":"crossref","first-page":"B4","DOI":"10.1016\/j.jid.2019.06.015","article-title":"CRISPR\/Cas9 for HTLV-1: a novel therapeutic approach to the first discovered human retrovirus","volume":"139","author":"Baker","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.jviromet.2026.115447_bib76","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1473-3099(16)30226-2","article-title":"Congenital cytomegalovirus\u2014a neglected health problem","volume":"16","author":"Kirby","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jviromet.2026.115447_bib77","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.virol.2019.01.021","article-title":"Editing the human cytomegalovirus genome with the CRISPR\/Cas9 system","volume":"529","author":"King","year":"2019","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.jviromet.2026.115447_bib78","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3390\/v13112258","article-title":"CRISPR screening: molecular tools for studying virus\u2013host interactions","volume":"13","author":"Chulanov","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib79","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"cell"},{"issue":"9","key":"10.1016\/j.jviromet.2026.115447_bib80","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41564-020-0727-8","article-title":"Gangliosides are essential endosomal receptors for quasi-enveloped and naked hepatitis A virus","volume":"5","author":"Das","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib81","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.10.028","article-title":"Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection","volume":"184","author":"Wei","year":"2021","journal-title":"Cell"},{"issue":"105","key":"10.1016\/j.jviromet.2026.115447_bib82","first-page":"255","article-title":"The CRISPR\/Cas9 genome editing methodology as a weapon against human viruses","volume":"19","author":"White","year":"2015","journal-title":"Discov. Med."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib83","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/v10010050","article-title":"CRISPR\/Cas9\u2014advancing orthopoxvirus genome editing for vaccine and vector development","volume":"10","author":"Okoli","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2026.115447_bib84","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s10529-015-1796-2","article-title":"A simple and rapid approach to manipulate pseudorabies virus genome by CRISPR\/Cas9 system","volume":"37","author":"Xu","year":"2015","journal-title":"Biotechnol. Lett."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib85","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1038\/srep19176","article-title":"A CRISPR\/Cas9 and Cre\/Lox system-based express vaccine development strategy against re-emerging Pseudorabies virus","volume":"6","author":"Liang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib86","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1038\/s41598-018-21575-8","article-title":"CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses","volume":"8","author":"Borca","year":"2018","journal-title":"Sci. Rep."},{"issue":"6366","key":"10.1016\/j.jviromet.2026.115447_bib87","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.aaq0180","article-title":"RNA editing with CRISPR-Cas13","volume":"358","author":"Cox","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib88","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12033-022-00567-0","article-title":"A review on the mechanism and applications of CRISPR\/Cas9\/Cas12\/Cas13\/Cas14 proteins utilized for genome engineering","volume":"65","author":"Hillary","year":"2023","journal-title":"Mol. Biotechnol."},{"issue":"6336","key":"10.1016\/j.jviromet.2026.115447_bib89","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.aam9321","article-title":"Nucleic acid detection with CRISPR-Cas13a\/C2c2","volume":"356","author":"Gootenberg","year":"2017","journal-title":"Science"},{"issue":"6387","key":"10.1016\/j.jviromet.2026.115447_bib90","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.aaq0179","article-title":"Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6","volume":"360","author":"Gootenberg","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jviromet.2026.115447_bib91","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.molcel.2016.12.023","article-title":"Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28","volume":"65","author":"Smargon","year":"2017","journal-title":"Mol. Cell."},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib92","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5811\/westjem.2020.4.47370","article-title":"The appropriate use of testing for COVID-19","volume":"21","author":"Zitek","year":"2020","journal-title":"West. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.jviromet.2026.115447_bib93","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib94","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1039\/D1BM01658J","article-title":"Non-viral delivery of the CRISPR\/Cas system: DNA versus RNA versus RNP","volume":"10","author":"Lin","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jviromet.2026.115447_bib95","unstructured":"Biosciences, S. Sherlock Biosciences Announces Clinical Data from Dartmouth-Hitchcock Health\u2019s Pilot Study of Sherlock\u2122 CRISPR SARS-CoV-2 Kit. 2020; Available from: https:\/\/sherlock.bio\/sherlock-biosciences-announces-clinical-data-from-dartmouth-hitchcock-health-pilot-study-of-sherlock-crispr-sars-cov-2-kit\/."},{"issue":"6387","key":"10.1016\/j.jviromet.2026.115447_bib96","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aar6245","article-title":"CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity","volume":"360","author":"Chen","year":"2018","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jviromet.2026.115447_bib97","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41551-020-00603-x","article-title":"Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA","volume":"4","author":"Patchsung","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.jviromet.2026.115447_bib98","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1166\/jbn.2019.2742","article-title":"CRISPR-Cas13a nanomachine based simple technology for avian influenza A (H7N9) virus on-site detection","volume":"15","author":"Liu","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nbt.3737","article-title":"Multiplex gene editing by CRISPR\u2013Cpf1 using a single crRNA array","volume":"35","author":"Zetsche","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"6455","key":"10.1016\/j.jviromet.2026.115447_bib100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.aay4198","article-title":"CRISPR propels a smart hydrogel","volume":"365","author":"Han","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2026.115447_bib101","series-title":"Global Regulatory Outlook for CRISPRized Plants","first-page":"71","article-title":"Reagents and their delivery systems in CRISPR\/Cas","author":"Khan","year":"2024"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib102","article-title":"CRISPR\/Cas gene editing and delivery systems for cancer therapy","volume":"16","author":"Li","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnology"},{"key":"10.1016\/j.jviromet.2026.115447_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.973326","article-title":"Delivering the CRISPR\/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation","volume":"10","author":"Foley","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"12","key":"10.1016\/j.jviromet.2026.115447_bib104","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.3390\/ma14123164","article-title":"CRISPR-associated (CAS) effectors delivery via microfluidic cell-deformation Chip","volume":"14","author":"Peyravian","year":"2021","journal-title":"Materials"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12025","article-title":"Development of delivery strategies for CRISPR-Cas9 genome editing","volume":"1","author":"Liu","year":"2023","journal-title":"BMEMat"},{"issue":"6","key":"10.1016\/j.jviromet.2026.115447_bib106","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/biom10060839","article-title":"Recent advances in CRISPR\/Cas9 delivery strategies","volume":"10","author":"Yip","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.jviromet.2026.115447_bib107","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7150\/thno.47007","article-title":"Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR\/Cas9 genome editing","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.jviromet.2026.115447_bib108","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/cac2.12366","article-title":"Current updates of CRISPR\/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management","volume":"42","author":"Allemailem","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jviromet.2026.115447_bib109","article-title":"Google Patents","author":"Cann","year":"2019","journal-title":"Polynucleotide Enrich. Using. CRISPR-Cas. Syst."},{"key":"10.1016\/j.jviromet.2026.115447_bib110","article-title":"Targeted rna cleavage with crispr-cas","author":"ANDERSON","year":"2021","journal-title":"Int. Search. Report. (Art. 21 (3))"},{"key":"10.1016\/j.jviromet.2026.115447_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1103007","article-title":"Current approaches to CRISPR\/Cas9 delivery","volume":"10","author":"Uluda\u011f","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"16","key":"10.1016\/j.jviromet.2026.115447_bib112","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1021\/acs.accounts.3c00279","article-title":"Development of CRISPR\/Cas delivery systems for in vivo precision genome editing","volume":"56","author":"Chen","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"10","key":"10.1016\/j.jviromet.2026.115447_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110476","article-title":"Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms","volume":"38","author":"Tian","year":"2022","journal-title":"Cell. Rep."},{"key":"10.1016\/j.jviromet.2026.115447_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.895713","article-title":"Viral vectors for the in vivo delivery of CRISPR components: advances and challenges","volume":"10","author":"Asmamaw Mengstie","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jviromet.2026.115447_bib115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11248-021-00247-w","article-title":"A short overview of CRISPR-Cas technology and its application in viral disease control","volume":"30","author":"Ghorbani","year":"2021","journal-title":"Transgenic Res."},{"issue":"44","key":"10.1016\/j.jviromet.2026.115447_bib116","doi-asserted-by":"crossref","first-page":"21317","DOI":"10.1039\/C9NR01786K","article-title":"Non-viral delivery of CRISPR\/Cas9 complex using CRISPR-GPS nanocomplexes","volume":"11","author":"Jain","year":"2019","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib117","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1038\/s41598-020-66775-3","article-title":"Abrogation of PRRSV infectivity by CRISPR-Cas13b-mediated viral RNA cleavage in mammalian cells","volume":"10","author":"Cui","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib118","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s13346-023-01320-z","article-title":"Recent advances in the delivery and applications of nonviral CRISPR\/Cas9 gene editing","volume":"13","author":"Sinclair","year":"2023","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib119","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/pharmaceutics15030984","article-title":"The CRISPR\/Cas9 system delivered by extracellular vesicles","volume":"15","author":"Zhu","year":"2023","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.jviromet.2026.115447_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202200082","article-title":"Nonviral delivery of CRISPR\/Cas systems in mRNA format","volume":"2","author":"Liu","year":"2022","journal-title":"Adv. NanoBiomed Res."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib121","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ymthe.2021.06.003","article-title":"New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape","volume":"30","author":"van Hees","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jviromet.2026.115447_bib122","article-title":"Improved CRISPR\/Cas9 knock-in efficiency via the self-excising cassette (SEC) selection method in C. elegans","volume":"2021","author":"Huang","year":"2021","journal-title":"Micro Biol."},{"key":"10.1016\/j.jviromet.2026.115447_bib123","series-title":"Alzheimer's Disease and Advanced Drug Delivery Strategies","first-page":"139","article-title":"Nanotechnology-based delivery for CRISPR-Cas 9 cargo in Alzheimer's disease","author":"Rawal","year":"2024"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib124","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/crispr.2023.0034","article-title":"Whole-Genome Sequencing Reveals Rare Off-Target Mutations in MC1R-Edited Pigs Generated by Using CRISPR-Cas9 and Somatic Cell Nuclear Transfer","volume":"7","author":"Li","year":"2024","journal-title":"CRISPR J."},{"issue":"2","key":"10.1016\/j.jviromet.2026.115447_bib125","doi-asserted-by":"crossref","first-page":"bbad530","DOI":"10.1093\/bib\/bbad530","article-title":"CRISPR-DIPOFF: an interpretable deep learning approach for CRISPR Cas-9 off-target prediction","volume":"25","author":"Toufikuzzaman","year":"2024","journal-title":"Brief. Bioinf"},{"key":"10.1016\/j.jviromet.2026.115447_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113732","article-title":"CRISPR\/Cas-powered nanobiosensors for diagnostics","volume":"197","author":"Phan","year":"2022","journal-title":"Biosens. Bioelectron."},{"issue":"7","key":"10.1016\/j.jviromet.2026.115447_bib127","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1093\/nar\/gkab163","article-title":"Systematic in vitro specificity profiling reveals nicking defects in natural and engineered CRISPR\u2013Cas9 variants","volume":"49","author":"Murugan","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.jviromet.2026.115447_bib128","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","article-title":"Delivery aspects of CRISPR\/Cas for in vivo genome editing","volume":"52","author":"Wilbie","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jviromet.2026.115447_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.745559","article-title":"The application of CRISPR\/Cas systems for antiviral therapy","volume":"3","author":"Baddeley","year":"2021","journal-title":"Front. Genome Ed."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/pathogens12010056","article-title":"A landscape of CRISPR\/Cas technique for emerging viral disease diagnostics and therapeutics: progress and prospects","volume":"12","author":"Tripathi","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.jviromet.2026.115447_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112743","article-title":"Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections","volume":"148","author":"Najafi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib132","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.157","article-title":"Recent advances in the characterization of essential genes and development of a database of essential genes","volume":"3","author":"Liang","year":"2024","journal-title":"Imeta"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib133","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/pcmedi\/pbab014","article-title":"Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics","volume":"4","author":"Liu","year":"2021","journal-title":"Precis. Clin. Med."},{"key":"10.1016\/j.jviromet.2026.115447_bib134","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.omtm.2022.02.010","article-title":"A combinatorial CRISPR-Cas12a attack on HIV DNA","volume":"25","author":"Fan","year":"2022","journal-title":"Mol. Ther. Methods & Clin. Dev."},{"issue":"7","key":"10.1016\/j.jviromet.2026.115447_bib135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/bioengineering9070291","article-title":"Engineering CRISPR\/Cas13 system against RNA viruses: from diagnostics to therapeutics","volume":"9","author":"Xue","year":"2022","journal-title":"Bioengineering"},{"key":"10.1016\/j.jviromet.2026.115447_bib136","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ymeth.2015.08.012","article-title":"Optimization of a multiplex CRISPR\/Cas system for use as an antiviral therapeutic","volume":"91","author":"Kennedy","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.jviromet.2026.115447_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1037124","article-title":"Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatment","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jviromet.2026.115447_bib138","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3390\/cancers12071934","article-title":"Adenoviral vectors armed with PAPILLOMAVIRUs oncogene specific CRISPR\/Cas9 kill human-papillomavirus-induced cervical cancer cells","volume":"12","author":"Ehrke-Schulz","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.jviromet.2026.115447_bib139","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/pls.2018.21","article-title":"Anticipating emerging biotechnology threats: A case study of CRISPR","volume":"37","author":"Vogel","year":"2018","journal-title":"Polit. Life Sci."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib140","first-page":"12800","article-title":"A simple and rapid diagnostic method for 13 types of high-risk human papillomavirus (HR-HPV) detection using CRISPR-Cas12a technology","volume":"11","author":"Gong","year":"2021","journal-title":"Transgenic Res."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib141","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ymthe.2020.09.011","article-title":"CRISPR-Cas9-edited tacrolimus-resistant antiviral T cells for advanced adoptive immunotherapy in transplant recipients","volume":"29","author":"Amini","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jviromet.2026.115447_bib142","first-page":"2020","article-title":"Elucidation of remdesivir cytotoxicity pathways through genome-wide CRISPR-Cas9 screening and transcriptomics","author":"Akinci","year":"2020","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.jviromet.2026.115447_bib143","first-page":"872","article-title":"CRISPR technology challenge facing the numerical integrity of whole human genome DNA","volume":"1","author":"Perez","year":"2017","journal-title":"Nat. bioBiomedical J. Sci. Tech. Res. Eng."},{"key":"10.1016\/j.jviromet.2026.115447_bib144","series-title":"Global Regulatory Outlook for CRISPRized Plants","first-page":"447","article-title":"Chapter 20 - Challenges and prospects in the regulation of CRISPR-edited crops","author":"Adeel","year":"2024"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib145","doi-asserted-by":"crossref","DOI":"10.47611\/jsrhs.v12i3.5121","article-title":"The Ethical Concerns of CRISPR Editing in Embryos","volume":"12","author":"Pydipati","year":"2023","journal-title":"J. Stud. Res."},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib146","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11569-022-00425-y","article-title":"Ethics and genomic editing using the crispr-cas9 technique: Challenges and conflicts","volume":"16","author":"Lorenzo","year":"2022","journal-title":"Nanoethics"},{"issue":"4","key":"10.1016\/j.jviromet.2026.115447_bib147","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10487","article-title":"and R.T. Flaum, CRISPR Technology: A Jewish Legal Perspective.","volume":"13","author":"Loike","year":"2022","journal-title":"Rambam Maimonides Med. J."},{"issue":"2","key":"10.1016\/j.jviromet.2026.115447_bib148","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7202\/1089787ar","article-title":"CRISPR Gene-Therapy: A Critical Review of Ethical Concerns and a Proposal for Public Decision-Making","volume":"5","author":"Lange","year":"2022","journal-title":"Can. J. Bioeth."},{"key":"10.1016\/j.jviromet.2026.115447_bib149","series-title":"Proceedings of the 16th International RAIS Conference on Social Sciences and Humanities","article-title":"Legal and Ethical Concerns Regarding Gene Editing","author":"Stanciu","year":"2020"},{"key":"10.1016\/j.jviromet.2026.115447_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.657981","article-title":"The Challenge of CRISPR-Cas toward bioethics","volume":"12","author":"Gonzalez-Avila","year":"2021","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.jviromet.2026.115447_bib151","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3906\/biy-1912-52","article-title":"Bioethical issues in genome editing by CRISPR-Cas9 technology.","volume":"44","author":"Ayano\u011flu","year":"2020","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.jviromet.2026.115447_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115189","article-title":"CRISPR-based biosensors for pathogenic biosafety","volume":"228","author":"Yang","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jviromet.2026.115447_bib153","series-title":"CRISPRized Horticulture Crops","first-page":"507","article-title":"Biosafety and biosecurity consideration in CRISPR-Cas","author":"Hassan","year":"2024"},{"issue":"6","key":"10.1016\/j.jviromet.2026.115447_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2023.13005","article-title":"CRISPR\u2011based diagnostic approaches: Implications for rapid management of future pandemics","volume":"27","author":"Shariq","year":"2023","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.jviromet.2026.115447_bib155","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/eji.201747131","article-title":"CRISPR\/Cas9: A tool for immunological research","volume":"48","author":"Hochheiser","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jviromet.2026.115447_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1138596","article-title":"Immunogenicity of CRISPR therapeutics\u2014Critical considerations for clinical translation","volume":"11","author":"Ewaisha","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"W1","key":"10.1016\/j.jviromet.2026.115447_bib157","doi-asserted-by":"crossref","first-page":"W93","DOI":"10.1093\/nar\/gkad425","article-title":"CRISPRimmunity: an interactive web server for CRISPR-associated Important Molecular events and Modulators Used in geNome edIting Tool identifYing","volume":"51","author":"Zhou","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jviromet.2026.115447_bib158","doi-asserted-by":"crossref","first-page":"291","DOI":"10.54097\/hset.v45i.7443","article-title":"Cancer Research Using Crispr\/Cas9 Gene Editing Technology","volume":"45","author":"Li","year":"2023","journal-title":"Highlights Sci. Eng. Technol."},{"key":"10.1016\/j.jviromet.2026.115447_bib159","first-page":"2024","article-title":"PAM-free diagnostics with diverse type V CRISPR-Cas systems","author":"Rananaware","year":"2024","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12929-023-00932-4","article-title":"The future of CRISPR in Mycobacterium tuberculosis infection","volume":"30","author":"Zein-Eddine","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jviromet.2026.115447_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fpos.2021.793134","article-title":"Deciphering the fragmentation of the human genome editing regulatory landscape","volume":"3","author":"Mahalatchimy","year":"2022","journal-title":"Front. Political Sci."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib162","article-title":"A CRISPR-enhanced metagenomic NGS test to improve pandemic preparedness","volume":"3","author":"Chan","year":"2023","journal-title":"Cell. Rep. Methods"},{"issue":"20","key":"10.1016\/j.jviromet.2026.115447_bib163","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01135-18","article-title":"HIV-1 employs multiple mechanisms to resist Cas9\/single guide RNA targeting the viral primer binding site","volume":"92","author":"Wang","year":"2018","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.jviromet.2026.115447_bib164","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.3390\/cells11192964","article-title":"CRISPR-based therapeutic gene editing for Duchenne muscular dystrophy: advances, challenges and perspectives","volume":"11","author":"Chen","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib165","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3390\/ijms23031832","article-title":"CRISPR therapeutics for Duchenne muscular dystrophy","volume":"23","author":"Erkut","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115447_bib166","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41556-020-00620-7","article-title":"CRISPR technologies for precise epigenome editing","volume":"23","author":"Nakamura","year":"2021","journal-title":"Nat. Cell. Biol."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib167","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/microbiolres16050104","article-title":"Progress in CRISPR Technology for Antiviral Treatments: Genome Editing as a Potential Cure for Chronic Viral Infections","volume":"16","author":"Nouri","year":"2025","journal-title":"Microbiol. Res."},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib168","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/pcmedi\/pbab014","article-title":"Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics","volume":"4","author":"Liu","year":"2021","journal-title":"Precis. Clin. Med."},{"key":"10.1016\/j.jviromet.2026.115447_bib169","first-page":"2020","article-title":"Rapid, field-deployable nucleobase detection and identification using FnCas9","author":"Azhar","year":"2020","journal-title":"BioRxiv"},{"issue":"7","key":"10.1016\/j.jviromet.2026.115447_bib170","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s41587-020-0513-4","article-title":"CRISPR\u2013Cas12-based detection of SARS-CoV-2","volume":"38","author":"Broughton","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.jviromet.2026.115447_bib171","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1021\/acsnano.0c00022","article-title":"Clustered regularly interspaced short palindromic repeats\/Cas9-mediated lateral flow nucleic acid assay","volume":"14","author":"Wang","year":"2020","journal-title":"ACS nano"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115447_bib172","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/acs.analchem.7b04542","article-title":"Clustered regularly interspaced short palindromic repeats\/Cas9 triggered isothermal amplification for site-specific nucleic acid detection","volume":"90","author":"Huang","year":"2018","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115447_bib173","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cell.2016.04.059","article-title":"Rapid, low-cost detection of Zika virus using programmable biomolecular components","volume":"165","author":"Pardee","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2026.115447_bib174","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67130","article-title":"FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip","volume":"10","author":"Kumar","year":"2021","journal-title":"Elife"},{"issue":"23","key":"10.1016\/j.jviromet.2026.115447_bib175","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1039\/D2SC07067G","article-title":"Minimizing the off-target frequency of the CRISPR\/Cas9 system via zwitterionic polymer conjugation and peptide fusion","volume":"14","author":"Han","year":"2023","journal-title":"Chem. Sci."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093426001126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093426001126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:39:43Z","timestamp":1788770383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093426001126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":175,"alternative-id":["S0166093426001126"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2026.115447","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging techniques of CRISPR\/Cas system in antiviral therapy and diagnostics: Applications, limitations, and translational perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2026.115447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115447"}}